| Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy L Salerno, L Craxì, E Amodio, G Lo Coco Vaccines 9 (8), 927, 2021 | 62 | 2021 |
| An ethical algorithm for rationing life-sustaining treatment during the COVID-19 pandemic J Savulescu, M Vergano, L Craxì, D Wilkinson British journal of anaesthesia 125 (3), 253-258, 2020 | 59 | 2020 |
| Rationing in a pandemic: Lessons from Italy L Craxì, M Vergano, J Savulescu, D Wilkinson Asian Bioethics Review 12 (3), 325-330, 2020 | 48 | 2020 |
| Who Should Get COVID-19 Vaccine First? A Survey to Evaluate Hospital Workers’ Opinion L Craxì, A Casuccio, E Amodio, V Restivo Vaccines 9 (3), 189, 2021 | 38 | 2021 |
| Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study G Germani, D Angrisani, G Addolorato, M Merli, C Mazzarelli, C Tarli, ... American Journal of Transplantation 22 (4), 1191-1200, 2022 | 34 | 2022 |
| Ethical aspects of fecal microbiota transplantation (FMT) V Daloiso, R Minacori, P Refolo, D Sacchini, L Craxi, A Gasbarrini, ... Eur Rev Med Pharmacol Sci 19 (17), 3173-80, 2015 | 19 | 2015 |
| Prioritization of high-cost new drugs for HCV: making sustainability ethical L Craxì, D Sacchini, P Refolo, R Minacori, V Daloiso, G Ricci, R Bruno, ... Eur Rev Med Pharmacol Sci 20 (6), 1044-1051, 2016 | 18 | 2016 |
| A return to humane medicine: Osler’s legacy L Craxì, S Giardina, AG Spagnolo Infez Med 25 (3), 292-7, 2017 | 13 | 2017 |
| Ethical assessment of hepatitis C virus treatment: the lesson from first generation protease inhibitors D Sacchini, L Craxì, P Refolo, R Minacori, A Cicchetti, A Gasbarrini, ... Digestive and Liver Disease 47 (5), 351-355, 2015 | 12 | 2015 |
| Opportunistic co‐screening for HCV and COVID‐19‐related services: A creative response with a need for thoughtful reflection LA Kondili, L Craxì, M Andreoni, FS Mennini, H Razavi Liver International 42 (5), 960, 2022 | 8 | 2022 |
| HCV: the best cure possible or the best possible cure? L Craxi, C Camma, A Craxi Journal of viral hepatitis 22 (8), 627-629, 2015 | 6 | 2015 |
| Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy. Vaccines 2021, 9, 927 L Salerno, L Craxì, E Amodio, G Lo Coco s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 5 | 2021 |
| Breaking bad news: How to cope L Craxì, V Di Marco Elsevier BV 50 (8), 857-859, 2018 | 5 | 2018 |
| Beneficence and equity: how the covid-19 pandemic exposed our weaknesses in Italy L Craxì, M Vergano British Medical Journal Publishing Group, 2020 | 3 | 2020 |
| From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy LA Kondili, L Craxì, F Nava, S Babudieri, R D’Ambrosio, A Marcellusi, ... The Journal of Infectious Diseases 228 (Supplement_3), S211-S220, 2023 | 2 | 2023 |
| Inequities in primary liver cancer in Europe: The State of Play LA Kondili, JV Lazarus, P Jepsen, F Murray, JM Schattenberg, M Korenjak, ... Journal of Hepatology, 2024 | 1 | 2024 |
| La pandemia da COVID-19: mutamento e persistenze L Craxì, M Davide Bioetica 1, 191-208, 2022 | 1 | 2022 |
| Liver transplantation for severe alcoholic hepatitis: a multicentre Italian study G Giacomo, BL Saverio, A Giovanni, M Manuela, M Chiara, T Claudia, ... AMERICAN JOURNAL OF TRANSPLANTATION 22 (4), 1191-1200, 2022 | 1* | 2022 |
| Who Should Get COVID-19 Vaccine First? A Survey to Evaluate Hospital Workers’ Opinion. Vaccines 2021, 9, 189 L Craxì, A Casuccio, E Amodio, V Restivo s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| HCV Eradication: A Duty of the State, an Option for the Individual L Craxì Advances in Microbiology, Infectious Diseases and Public Health: Volume 14 …, 2020 | 1 | 2020 |
